CRISPR遺伝子編集の世界市場レポート 2025年

CRISPR遺伝子編集市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR27.1％で75億1,000万米ドルに成長します。予測期間の成長は、遺伝性疾患の有病率の増加、精密医療への重点の高まり、CRISPR研究開発への投資の増加、老年人口の増加、遺伝子治療手技の注目の高まりに起因します。予測期間の主な動向には、遺伝子編集技術の進歩、研究開発数の拡大、ドラッグデリバリー方法の革新、CRISPR編集農業の採用などが含まれます。

遺伝性疾患の有病率の上昇は、今後数年間のCRISPR遺伝子編集市場の成長を促進すると予想されます。遺伝性疾患は、ゲノムの異常によって引き起こされる健康状態であり、単一の遺伝子（単遺伝子性）、複数の遺伝子（多遺伝子性）、または染色体異常の変異に起因する可能性があります。これらの疾患の罹患率の増加は、遺伝子の突然変異、人口の高齢化、近親婚などの要因によるものです。CRISPR遺伝子編集は、DNAの正確で標的を絞った改変を可能にすることで、遺伝性疾患の管理において重要な役割を果たしています。科学者たちはCRISPRを用いて、特定の変異を特定し、修正し、正常な遺伝子機能を回復させ、嚢胞性線維症や鎌状赤血球貧血などの症状を緩和しています。例えば、2022年7月、米国の非営利団体である嚢胞性線維症（CF）財団は、嚢胞性線維症患者の増加を報告し、米国では2022年に約4万人の子供と成人が罹患し、世界では10万5,000人以上が診断されています。したがって、遺伝性疾患の有病率の増加がCRISPR遺伝子編集市場の成長を促進しています。

CRISPR遺伝子編集市場の主要企業は、顧客基盤の拡大、売上の増加、収益の向上を図るため、遺伝子治療などの革新的製品の開発に注力しています。遺伝子治療は、遺伝子を用いて病気や障害を治療、予防、治癒する医療アプローチです。例えば、2023年12月、米国食品医薬品局（FDA）は、鎌状赤血球症を治療するための細胞ベースの遺伝子治療であるCasgevyを承認しました。CasgevyはCRISPR/Cas9技術を用いて造血幹細胞を改変し、この遺伝性疾患に対する有望な治療選択肢を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界CRISPR遺伝子編集 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のCRISPR遺伝子編集市場：成長率分析
• 世界のCRISPR遺伝子編集市場の実績：規模と成長, 2019-2024
• 世界のCRISPR遺伝子編集市場の予測：規模と成長, 2024-2029, 2034F
• 世界CRISPR遺伝子編集総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のCRISPR遺伝子編集市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• CRISPR関連ヌクレアーゼ（Casヌクレアーゼ）
• ガイドリボ核酸（RNA）
• デオキシリボ核酸（DNA）リガーゼ
• 制限エンドヌクレアーゼ
• その他のタイプ
• 世界のCRISPR遺伝子編集市場：サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• デザインツール
• プラスミドとベクター
• CRISPR関連タンパク質9（Cas9）とガイドリボ核酸（g-RNA）
• デリバリーシステム製品
• その他のサービス
• 世界のCRISPR遺伝子編集市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• CRISPRまたはCas9
• ジンクフィンガーヌクレアーゼ
• その他のテクノロジー
• 世界のCRISPR遺伝子編集市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 農業
• バイオメディカル
• 産業
• ゲノム工学
• 疾患モデル
• 機能ゲノミクス
• その他の用途
• 世界のCRISPR遺伝子編集市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 学術機関および研究センター
• バイオテクノロジー企業
• 契約調査機関（CRO）
• 製薬およびバイオ医薬品企業
• 世界のCRISPR遺伝子編集市場CRISPR関連ヌクレアーゼ（Casヌクレアーゼ）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• Cas9
• Cas12
• Cas13
• その他のCasヌクレアーゼ
• 世界のCRISPR遺伝子編集市場、ガイドリボ核酸（RNA）のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• シングルガイドRNA（sgRNA）
• デュアルガイドRNA
• 合成ガイドRNA
• 世界のCRISPR遺伝子編集市場デオキシリボ核酸（DNA）リガーゼの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• T4 DNAリガーゼ
• 大腸菌DNAリガーゼ
• その他のDNAリガーゼ
• 世界のCRISPR遺伝子編集市場制限酵素のサブセグメンテーション（種類別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• II型制限酵素
• I型およびIII型制限酵素
• その他の制限酵素
• 世界のCRISPR遺伝子編集市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• CRISPRデリバリーシステム
• CRISPRプラスミド
• CRISPRベースの診断ツール

第7章 地域別・国別分析

• 世界のCRISPR遺伝子編集市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のCRISPR遺伝子編集市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• CRISPR遺伝子編集市場：競合情勢
• CRISPR遺伝子編集市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GenScript Overview, Products and Services, Strategy and Financial Analysis
  • Integrated DNA Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Takara Bio Inc.
• OriGene Technologies Inc.
• Intellia Therapeutics Inc.
• New England Biolabs
• Synthego
• Arbor Biotechnologies Inc.
• Rockland Immunochemicals Inc.
• Cellectis
• Editas Medicine
• Caribou Biosciences Inc.
• System Biosciences LLC
• Applied StemCell
• Addgene
• Mirus Bio LLC
• Excision BioTherapeutics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• CRISPR遺伝子編集市場2029：新たな機会を提供する国
• CRISPR遺伝子編集市場2029：新たな機会を提供するセグメント
• CRISPR遺伝子編集市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Clustered regularly interspaced short palindromic repeats (CRISPR) gene editing stands as a groundbreaking biotechnological tool that enables precise modifications to the DNA of living organisms. This technology harnesses a natural defense mechanism found in bacteria, where CRISPR sequences in DNA are utilized to identify and cut specific genetic sequences. CRISPR gene editing empowers scientists to add, remove, or alter genetic material with remarkable precision, making it a potent technique for research, therapeutic interventions, and potential treatments for genetic disorders.

The primary types of CRISPR gene editing encompass CRISPR-associated nuclease (Cas nuclease), guide RNA, DNA ligase, restriction endonuclease, and other related components. CRISPR-associated nuclease, commonly known as Cas nuclease, functions as molecular scissors, cleaving targeted DNA sequences as directed by CRISPR. This aspect focuses on the development and utilization of Cas proteins for precise gene editing, offering promising applications across industries such as agriculture, medicine, and biotechnology. It offers diverse services including design tools, plasmids, CRISPR-associated protein 9 (Cas9) and guide RNA (gRNA), delivery systems, and more. Additionally, it encompasses various technologies such as CRISPR/Cas9, zinc finger nucleases, and others, serving applications such as agriculture, biomedical research, industrial processes, genome engineering, disease modeling, functional genomics, and more. These solutions cater to a range of end users including academic institutions, research centers, biotech firms, contract research organizations (CROs), pharmaceutical companies, and biopharmaceutical companies.

The CRISPR gene editing market research report is one of a series of new reports from The Business Research Company that provides CRISPR gene editing market statistics, including the CRISPR gene editing industry global market size, regional shares, competitors with CRISPR gene editing market share, detailed CRISPR gene editing market segments, market trends, and opportunities, and any further data you may need to thrive in the CRISPR gene editing industry. These CRISPR gene editing market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The CRISPR gene editing market size has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88 billion in 2025 at a compound annual growth rate (CAGR) of 27.4%. The growth in the historic period can be attributed to increased demand for genome editing technologies, rise in government funding, increased cancer cases, increased prevalence of chronic diseases, increased awareness about CRISPR technology, rise healthcare infrastructure.

The CRISPR gene editing market size is expected to see exponential growth in the next few years. It will grow to $7.51 billion in 2029 at a compound annual growth rate (CAGR) of 27.1%. The growth in the forecast period can be attributed to increasing prevalence of genetic disorders, growing emphasis on precision medicine, rising investment in CRISPR research and development, increasing geriatric population, growing prominence for the gene therapy procedures. Major trends in the forecast period include advancements in gene editing technology, expansion in the number of research studies, drug discovery and development, innovation in delivery methods, adoption of CRISPR-edited agriculture.

The rising prevalence of genetic disorders is expected to drive the growth of the CRISPR gene editing market in the coming years. Genetic disorders are health conditions caused by abnormalities in the genome, which can result from mutations in a single gene (monogenic), multiple genes (polygenic), or chromosomal abnormalities. The increasing incidence of these disorders is due to factors such as genetic mutations, aging populations, and consanguineous marriages. CRISPR gene editing plays a crucial role in managing genetic disorders by enabling precise and targeted modifications to DNA. Scientists use CRISPR to identify and correct specific mutations, restore normal gene function, and alleviate symptoms in conditions like cystic fibrosis and sickle cell anemia. For example, in July 2022, the Cystic Fibrosis (CF) Foundation, a US-based non-profit organization, reported a rise in cystic fibrosis cases, with nearly 40,000 children and adults in the United States affected in 2022, and over 105,000 people diagnosed worldwide. Therefore, the increasing prevalence of genetic disorders is driving the growth of the CRISPR gene editing market.

Major companies in the CRISPR gene editing market are focusing on developing innovative products, such as gene therapy, to expand their customer base, increase sales, and boost revenue. Gene therapy is a medical approach that uses genes to treat, prevent, or cure diseases and disorders. For example, in December 2023, the US Food and Drug Administration (FDA) approved Casgevy, a cell-based gene therapy for treating sickle cell disease. Casgevy employs CRISPR/Cas9 technology to modify hematopoietic stem cells, offering a promising treatment option for this genetic disorder.

In January 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology company, entered a four-year research collaboration with Beam Therapeutics. This collaboration focuses on three programs targeting rare genetic diseases affecting the liver, muscles, and central nervous system, leveraging CRISPR gene editing technology. Beam Therapeutics is a US-based biotechnology company specializing in CRISPR gene editing.

Major companies operating in the CRISPR gene editing market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., GenScript, Integrated DNA Technologies Inc., Takara Bio Inc., OriGene Technologies Inc., Intellia Therapeutics Inc., New England Biolabs, Synthego, Arbor Biotechnologies Inc., Rockland Immunochemicals Inc., Cellectis, Editas Medicine, Caribou Biosciences Inc., System Biosciences LLC, Applied StemCell, Addgene, Mirus Bio LLC, Excision BioTherapeutics Inc., GeneCopoeia Inc., ToolGen Inc., Cellecta Inc., CRISPR Therapeutics, ERS Genomics Limited

North America was the largest region in the CRISPR gene editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the CRISPR gene editing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The CRISPR gene editing market includes of revenues earned by entities by providing services such as gRNA design and vector construction, cell line and engineering, screening services, drug development services, and gene therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The CRISPR gene editing market also includes sales of gene editing vectors, laboratory equipment, kits and enzymes, libraries, design tools, antibodies, bioinformatics tools, and cell culture equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

CRISPR Gene Editing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on crispr gene editing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for crispr gene editing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The crispr gene editing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: CRISPR-Associated Nuclease (Cas Nuclease); Guide Ribonucleic Acid (RNA); Deoxyribonucleic Acid (DNA) Ligase; Restriction Endonuclease; Other Types
• 2) By Services: Design Tools; Plasmid And Vector; CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA); Delivery System Products; Other Services
• 3) By Technology: CRISPR Or Cas9; Zinc Finger Nucleases; Other Technologies
• 4) By Application: Agricultural; Biomedical; Industrial; Genome Engineering; Disease Models; Functional Genomics; Other Applications
• 5) By End User: Academic Institutes And Research Centers; Biotechnology Companies; Contract Research Organizations (CROs); Pharmaceutical And Biopharmaceutical Companies
• Subsegments:
• 1) By CRISPR-Associated Nuclease (Cas Nuclease): Cas9; Cas12; Cas13; Other Cas Nucleases
• 2) By Guide Ribonucleic Acid (RNA): Single-guide RNA (sgRNA); Dual-guide RNA; Synthetic Guide RNA
• 3) By Deoxyribonucleic Acid (DNA) Ligase: T4 DNA Ligase; E. coli DNA Ligase; Other DNA Ligases
• 4) By Restriction Endonuclease: Type II Restriction Enzymes; Type I And III Restriction Enzymes; Other Restriction Enzymes
• 5) By Other Types: CRISPR Delivery Systems; CRISPR Plasmids; CRISPR-Based Diagnostic Tools
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Agilent Technologies Inc.; GenScript; Integrated DNA Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. CRISPR Gene Editing Market Characteristics

3. CRISPR Gene Editing Market Trends And Strategies

4. CRISPR Gene Editing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global CRISPR Gene Editing Growth Analysis And Strategic Analysis Framework

• 5.1. Global CRISPR Gene Editing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global CRISPR Gene Editing Market Growth Rate Analysis
• 5.4. Global CRISPR Gene Editing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global CRISPR Gene Editing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global CRISPR Gene Editing Total Addressable Market (TAM)

6. CRISPR Gene Editing Market Segmentation

• 6.1. Global CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR-Associated Nuclease (Cas Nuclease)
• Guide Ribonucleic Acid (RNA)
• Deoxyribonucleic Acid (DNA) Ligase
• Restriction Endonuclease
• Other Types
• 6.2. Global CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Design Tools
• Plasmid And Vector
• CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA)
• Delivery System Products
• Other Services
• 6.3. Global CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR Or Cas9
• Zinc Finger Nucleases
• Other Technologies
• 6.4. Global CRISPR Gene Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Agricultural
• Biomedical
• Industrial
• Genome Engineering
• Disease Models
• Functional Genomics
• Other Applications
• 6.5. Global CRISPR Gene Editing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic Institutes And Research Centers
• Biotechnology Companies
• Contract Research Organizations (CROs)
• Pharmaceutical And Biopharmaceutical Companies
• 6.6. Global CRISPR Gene Editing Market, Sub-Segmentation Of CRISPR-Associated Nuclease (Cas Nuclease), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cas9
• Cas12
• Cas13
• Other Cas Nucleases
• 6.7. Global CRISPR Gene Editing Market, Sub-Segmentation Of Guide Ribonucleic Acid (RNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-guide RNA (sgRNA)
• Dual-guide RNA
• Synthetic Guide RNA
• 6.8. Global CRISPR Gene Editing Market, Sub-Segmentation Of Deoxyribonucleic Acid (DNA) Ligase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• T4 DNA Ligase
• E. coli DNA Ligase
• Other DNA Ligases
• 6.9. Global CRISPR Gene Editing Market, Sub-Segmentation Of Restriction Endonuclease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Type II Restriction Enzymes
• Type I And III Restriction Enzymes
• Other Restriction Enzymes
• 6.10. Global CRISPR Gene Editing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR Delivery Systems
• CRISPR Plasmids
• CRISPR-Based Diagnostic Tools

7. CRISPR Gene Editing Market Regional And Country Analysis

• 7.1. Global CRISPR Gene Editing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global CRISPR Gene Editing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific CRISPR Gene Editing Market

• 8.1. Asia-Pacific CRISPR Gene Editing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China CRISPR Gene Editing Market

• 9.1. China CRISPR Gene Editing Market Overview
• 9.2. China CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India CRISPR Gene Editing Market

• 10.1. India CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan CRISPR Gene Editing Market

• 11.1. Japan CRISPR Gene Editing Market Overview
• 11.2. Japan CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia CRISPR Gene Editing Market

• 12.1. Australia CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia CRISPR Gene Editing Market

• 13.1. Indonesia CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea CRISPR Gene Editing Market

• 14.1. South Korea CRISPR Gene Editing Market Overview
• 14.2. South Korea CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe CRISPR Gene Editing Market

• 15.1. Western Europe CRISPR Gene Editing Market Overview
• 15.2. Western Europe CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK CRISPR Gene Editing Market

• 16.1. UK CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany CRISPR Gene Editing Market

• 17.1. Germany CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France CRISPR Gene Editing Market

• 18.1. France CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy CRISPR Gene Editing Market

• 19.1. Italy CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain CRISPR Gene Editing Market

• 20.1. Spain CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe CRISPR Gene Editing Market

• 21.1. Eastern Europe CRISPR Gene Editing Market Overview
• 21.2. Eastern Europe CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia CRISPR Gene Editing Market

• 22.1. Russia CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America CRISPR Gene Editing Market

• 23.1. North America CRISPR Gene Editing Market Overview
• 23.2. North America CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA CRISPR Gene Editing Market

• 24.1. USA CRISPR Gene Editing Market Overview
• 24.2. USA CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada CRISPR Gene Editing Market

• 25.1. Canada CRISPR Gene Editing Market Overview
• 25.2. Canada CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America CRISPR Gene Editing Market

• 26.1. South America CRISPR Gene Editing Market Overview
• 26.2. South America CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil CRISPR Gene Editing Market

• 27.1. Brazil CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East CRISPR Gene Editing Market

• 28.1. Middle East CRISPR Gene Editing Market Overview
• 28.2. Middle East CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa CRISPR Gene Editing Market

• 29.1. Africa CRISPR Gene Editing Market Overview
• 29.2. Africa CRISPR Gene Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa CRISPR Gene Editing Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa CRISPR Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. CRISPR Gene Editing Market Competitive Landscape And Company Profiles

• 30.1. CRISPR Gene Editing Market Competitive Landscape
• 30.2. CRISPR Gene Editing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GenScript Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Integrated DNA Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. CRISPR Gene Editing Market Other Major And Innovative Companies

• 31.1. Takara Bio Inc.
• 31.2. OriGene Technologies Inc.
• 31.3. Intellia Therapeutics Inc.
• 31.4. New England Biolabs
• 31.5. Synthego
• 31.6. Arbor Biotechnologies Inc.
• 31.7. Rockland Immunochemicals Inc.
• 31.8. Cellectis
• 31.9. Editas Medicine
• 31.10. Caribou Biosciences Inc.
• 31.11. System Biosciences LLC
• 31.12. Applied StemCell
• 31.13. Addgene
• 31.14. Mirus Bio LLC
• 31.15. Excision BioTherapeutics Inc.

32. Global CRISPR Gene Editing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The CRISPR Gene Editing Market

34. Recent Developments In The CRISPR Gene Editing Market

35. CRISPR Gene Editing Market High Potential Countries, Segments and Strategies

• 35.1 CRISPR Gene Editing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 CRISPR Gene Editing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 CRISPR Gene Editing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer